X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1585) 1585
Patent (44) 44
Newspaper Article (34) 34
Conference Proceeding (12) 12
Dissertation (10) 10
Book Chapter (9) 9
Magazine Article (3) 3
Book / eBook (2) 2
Reference (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (476) 476
male (289) 289
female (287) 287
animals (235) 235
analysis (191) 191
adult (153) 153
middle aged (146) 146
research (136) 136
cancer (121) 121
expression (121) 121
aged (110) 110
biochemistry & molecular biology (107) 107
oncology (107) 107
mice (106) 106
apoptosis (105) 105
gene expression (104) 104
proteins (104) 104
health aspects (99) 99
medicine (98) 98
cell biology (89) 89
research article (88) 88
studies (83) 83
care and treatment (81) 81
pharmacology & pharmacy (76) 76
risk factors (76) 76
oxidative stress (71) 71
genetic aspects (68) 68
rats (66) 66
chemistry, multidisciplinary (65) 65
materials science, multidisciplinary (64) 64
multidisciplinary sciences (61) 61
cell line, tumor (59) 59
activation (56) 56
adolescent (56) 56
inflammation (56) 56
chemistry, physical (55) 55
children (55) 55
genes (54) 54
disease (53) 53
pregnancy (53) 53
risk (53) 53
growth (52) 52
metastasis (52) 52
young adult (52) 52
in-vitro (50) 50
diagnosis (49) 49
medical research (49) 49
prognosis (48) 48
signal transduction (48) 48
singapore (48) 48
neurosciences (47) 47
stem cells (47) 47
tumors (47) 47
medicine, research & experimental (46) 46
chemotherapy (45) 45
nanoparticles (45) 45
physiological aspects (45) 45
kinases (44) 44
prospective studies (44) 44
biology (42) 42
china (42) 42
inhibition (42) 42
nutrition & dietetics (42) 42
prevalence (42) 42
rats, sprague-dawley (42) 42
therapy (42) 42
patients (41) 41
protein (41) 41
science (41) 41
biotechnology & applied microbiology (40) 40
cells, cultured (40) 40
immunology (40) 40
mutation (40) 40
physics, applied (40) 40
age (39) 39
cells (39) 39
metabolism (39) 39
hospitals (38) 38
apoptosis - drug effects (37) 37
cell proliferation (37) 37
child (37) 37
life sciences (37) 37
survival (37) 37
aged, 80 and over (36) 36
microbiology (36) 36
phosphorylation (36) 36
usage (36) 36
cancer therapies (35) 35
child, preschool (35) 35
diabetes (35) 35
gene-expression (35) 35
treatment outcome (35) 35
cohort studies (34) 34
genomics (34) 34
nanoscience & nanotechnology (34) 34
rodents (34) 34
genetics & heredity (33) 33
mortality (33) 33
plant sciences (33) 33
chemistry, medicinal (32) 32
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1575) 1575
Chinese (131) 131
French (14) 14
Korean (3) 3
Japanese (2) 2
Malay (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS genetics, ISSN 1553-7404, 2018, Volume 14, Issue 5, p. e1007391
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0123587
...About the Authors: Amit Jain Affiliation: Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore Cindy Lim Affiliation: Clinical... 
SURVIVAL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | EXON 19 | SMOKERS | MULTIDISCIPLINARY SCIENCES | OPEN-LABEL | CANCER | ERLOTINIB | CHEMOTHERAPY | Smoking - adverse effects | Lung Neoplasms - drug therapy | Multivariate Analysis | Demography | Adenocarcinoma of Lung | Humans | Middle Aged | ErbB Receptors - genetics | Reflex - drug effects | Male | Brain Neoplasms - secondary | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Lung Neoplasms - genetics | Brain Neoplasms - enzymology | ErbB Receptors - antagonists & inhibitors | Lung Neoplasms - enzymology | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Treatment Outcome | Mutation - genetics | Adenocarcinoma - drug therapy | Disease Progression | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Aged | Protein Kinase Inhibitors - pharmacology | Neoplasm Staging | Cohort Studies | Adenocarcinoma | Brain | Laboratories | Lung cancer | Clinical trials | Critical care | Oncology | Metastasis | Males | Multivariate analysis | Cancer therapies | Metastases | Epidermal growth factor | Protein-tyrosine kinase receptors | Chi square analysis | Diagnosis | Protein-tyrosine kinase | Tyrosine | Epidermal growth factor receptors | Survival | Patients | Medicine | Pathology | Survival analysis | Chemotherapy | Brain research | Hospitals | Medical prognosis | Mutation | Females | Smoking
Journal Article
Journal Article
by Pelaz, Beatriz and Alexiou, Christoph and Alvarez-Puebla, Ramon A and Alves, Frauke and Andrews, Anne M and Ashraf, Sumaira and Balogh, Lajos P and Ballerini, Laura and Bestetti, Alessandra and Brendel, Cornelia and Bosi, Susanna and Carril, Monica and Chan, Warren C. W and Chen, Chunying and Chen, Xiaodong and Chen, Xiaoyuan and Cheng, Zhen and Cui, Daxiang and Du, Jianzhong and Dullin, Christian and Escudero, Alberto and Feliu, Neus and Gao, Mingyuan and George, Michael and Gogotsi, Yury and Grünweller, Arnold and Gu, Zhongwei and Halas, Naomi J and Hampp, Norbert and Hartmann, Roland K and Hersam, Mark C and Hunziker, Patrick and Jian, Ji and Jiang, Xingyu and Jungebluth, Philipp and Kadhiresan, Pranav and Kataoka, Kazunori and Khademhosseini, Ali and Kopeček, Jindřich and Kotov, Nicholas A and Krug, Harald F and Lee, Dong Soo and Lehr, Claus-Michael and Leong, Kam W and Liang, Xing-Jie and Ling Lim, Mei and Liz-Marzán, Luis M and Ma, Xiaowei and Macchiarini, Paolo and Meng, Huan and Möhwald, Helmuth and Mulvaney, Paul and Nel, Andre E and Nie, Shuming and Nordlander, Peter and Okano, Teruo and Oliveira, Jose and Park, Tai Hyun and Penner, Reginald M and Prato, Maurizio and Puntes, Victor and Rotello, Vincent M and Samarakoon, Amila and Schaak, Raymond E and Shen, Youqing and Sjöqvist, Sebastian and Skirtach, Andre G and Soliman, Mahmoud G and Stevens, Molly M and Sung, Hsing-Wen and Tang, Ben Zhong and Tietze, Rainer and Udugama, Buddhisha N and VanEpps, J. Scott and Weil, Tanja and Weiss, Paul S and Willner, Itamar and Wu, Yuzhou and Yang, Lily and Yue, Zhao and Zhang, Qian and Zhang, Qiang and Zhang, Xian-En and Zhao, Yuliang and Zhou, Xin and Parak, Wolfgang J
ACS Nano, ISSN 1936-0851, 03/2017, Volume 11, Issue 3, pp. 2313 - 2381
Journal Article
Nature nanotechnology, ISSN 1748-3395, 2013, Volume 8, Issue 5, pp. 356 - 362
..., Rui-Qi Png2, Wei-Ling Seah2, Jing-Mei Zhuo2, Geok-Kieng Lim2,3, Peter K. H. Ho2 and Lay-Lay Chua1,2* Recent advances in chemical vapour deposition have led... 
LARGE-AREA | LAYER GRAPHENE | MOS DEVICES | FILMS | CHEMICAL-VAPOR-DEPOSITION | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | CHARGE | DIELECTRIC-BREAKDOWN | Thin films | Graphene | Capacitors | Sheet metal | Dielectrics | Polymeric films | Gates | Contact
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e54522
..., United States of America Winnie Yeo Affiliation: Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China Mei-Yi Michelle Chan Affiliation... 
HISTONE DEACETYLASE INHIBITOR | IN-VITRO | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | PHASE-II | T-CELL LYMPHOMA | OVARIAN-CANCER | IDENTIFICATION | UGT1A1-ASTERISK-28 GENOTYPE | TUMORS | VORINOSTAT | Humans | Microsomes, Liver - metabolism | Substrate Specificity | Antineoplastic Agents - toxicity | Antineoplastic Agents - metabolism | Glucuronosyltransferase - genetics | Histone Deacetylase Inhibitors - pharmacokinetics | Carcinoma, Hepatocellular - genetics | Antineoplastic Agents - pharmacokinetics | Liver Neoplasms - enzymology | Hydroxamic Acids - toxicity | Gene Expression | Liver Neoplasms - genetics | Drug Stability | Metabolome | Genotype | Carcinoma, Hepatocellular - enzymology | Sulfonamides - pharmacokinetics | Hydroxamic Acids - pharmacokinetics | Hydroxamic Acids - metabolism | Glucuronosyltransferase - metabolism | Metabolic Networks and Pathways | Histone Deacetylase Inhibitors - toxicity | Liver Neoplasms - metabolism | Sulfonamides - metabolism | Sulfonamides - toxicity | Kinetics | Histone Deacetylase Inhibitors - metabolism | Carcinoma, Hepatocellular - metabolism | Hydrogen-Ion Concentration | Antimitotic agents | Medical research | Liver cancer | Enzymes | Cancer patients | Care and treatment | Metabolites | Physiological aspects | Medicine, Experimental | Non-Hodgkin's lymphomas | Antineoplastic agents | T cells | Histone deacetylase | Liver | Genomics | Clinical trials | Science | Oncology | Hepatocellular carcinoma | Lymphocytes T | Cancer therapies | Genotype & phenotype | Drug dosages | Neutropenia | Hematology | Pharmacology | FDA approval | Metabolism | Patients | Lymphoma | Substrates | Microsomes | Chromatography | Acids | Pharmacy | Epigenetics | Lymphomas | Pharmacokinetics | T-cell lymphoma | Cancer
Journal Article
BMC medicine, ISSN 1741-7015, 2017, Volume 15, Issue 1, p. 50
Journal Article
BMC cancer, ISSN 1471-2407, 2018, Volume 18, Issue 1, pp. 1198 - 9
...Author(s): Wan-Ling Tan[sup.1], Quan Sing Ng[sup.1], Cindy Lim[sup.2], Eng Huat Tan[sup.1], Chee Keong Toh[sup.1], Mei-Kim Ang[sup.1], Ravindran Kanesvaran[sup... 
EGFR mutation NSCLC | Brain metastases | Metastatic | Afatinib | Dose | RECEPTOR GENE-MUTATIONS | GEFITINIB | EFFICACY | SAFETY | ADENOCARCINOMA | CELL LUNG-CANCER | ONCOLOGY | INTERNATIONAL-ASSOCIATION | COMMON | ERLOTINIB | Metastasis | Drug therapy | Lung cancer, Non-small cell | Brain cancer | Patient outcomes
Journal Article